Simona King is the founder of Passage Bio. Passage Bio has raised $442M in total funding. Latest round: Growth. Based in Philadelphia, USA.
Simona King is the chief financial officer of Passage Bio, a clinical-stage genetic medicines company based in Philadelphia, PA. The company focuses on developing transformative therapies for central nervous system disorders with limited or no approved treatment options. Passage Bio is advancing three clinical programs in GM1 gangliosidosis, Krabbe disease, and frontotemporal dementia, with additional programs in preclinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library